Ultralife reports Q3 operating loss of $0.8M; revenue down 11% to $21.8M

ULTRALIFE CORP

2021-Q3 EPS reported $6.00 revenue$74,504,000

Net loss $0.6M ($0.04/diluted share); adjusted EPS unfavorably impacted by $0.08 from supply chain delays.
Revenue $21.8M, down 10.7% YoY; commercial sales up 5%, government/defense sales down 40%.
Delayed shipments from supply chain bottlenecks adversely impacted revenue by ~$4.1M in Q3.
Backlog increased ~22% sequentially; cash $15.9M, up 49% from year-end 2020; debt reduced to $0.3M.
Battery & Energy revenue down 8% to $20.0M; Communications Systems down 31% to $1.8M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.